(Q37907925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Leishmania antimony resistance: what we know what we can learn from the field (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Elodie Gazanion

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Baptiste Vergnes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Denis Sereno

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

Bruno Oury

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

29 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Parasitology Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1225-1232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21800124%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00436-011-2555-5

8 February 2020

exact match

0 references

cites work

Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

How can we identify parasite genes that underlie antimalarial drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Molecular mechanisms of antimony resistance in Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Control strategies for tuberculosis epidemics: new models for old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Monitoring drug resistance in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Drug resistance in leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Trypanothione Reductase from Leishmania donovani. Purification, Characterisation and Inhibition by Trivalent Antimonials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Metabolism and functions of trypanothione in the Kinetoplastida

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

In vitro cultivation and characterization of axenic amastigotes of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Modelling of the uptake rate of the nitrogen dioxide Palmes diffusive sampler based on the effect of environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Imaging Leishmania development in their host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Current diagnosis and treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Leishmania spp.: proficiency of drug-resistant parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Resistance mechanisms to arsenicals and antimonials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Leishmaniasis treatment--a challenge that remains: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Advances and perspectives in Leishmania cell based drug-screening procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Natural abundance of Sb and Sc in pristine groundwaters, Springwater Township, Ontario, Canada, and implications for tracing contamination from landfill leachates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Metabolomics to unveil and understand phenotypic diversity between pathogen populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Linking in vitro and in vivo survival of clinical Leishmania donovani strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Real-time PCR methods for monitoring antimalarial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2555-5

ABC transporters in Leishmania and their role in drug resistance

21 January 2018

1 reference

12 December 2020

Resistance to treatment in Kala-azar: speciation of isolates from northeast India

1 reference

12 December 2020

Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani

1 reference

12 December 2020

Distribution of antimony in contaminated grassland: 2--Small mammals and invertebrates

1 reference

12 December 2020

[Sensitivity of Leishmania spp. to antimony derivatives. Use of mouse peritoneal macrophages]

1 reference

12 December 2020

Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes

1 reference

12 December 2020

Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents

1 reference

12 December 2020

Antimony: global environmental contaminant

1 reference

12 December 2020

Increasing atmospheric antimony contamination in the northern hemisphere: snow and ice evidence from Devon Island, Arctic Canada

1 reference

12 December 2020

Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.

1 reference

12 December 2020

Interaction of trivalent antimony with a CCHC zinc finger domain: potential relevance to the mechanism of action of antimonial drugs

1 reference

12 December 2020

Heavy metal concentrations in groundwaters and soils of Thane Region of Maharashtra, India

1 reference

12 December 2020

Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation

1 reference

12 December 2020

Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.

1 reference

12 December 2020

Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony

1 reference

12 December 2020

In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis

1 reference

12 December 2020

Pentostam (sodium stibogluconate); a 50-year personal reminiscence

1 reference

12 December 2020

Biochemistry of Pentostam resistant Leishmania.

1 reference

12 December 2020

The fitness of antimony-resistant Leishmania parasites: lessons from the field

1 reference

12 December 2020

Characterization of natural antimony resistance in Leishmania donovani isolates.

1 reference

12 December 2020

Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.

1 reference

12 December 2020

Current scenario of drug development for leishmaniasis

1 reference

12 December 2020